19 Publications
2015
Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199.
Schneider, Bryan PSchneider, Bryan PSchneider, Bryan PLi, LangLi, LangLi, LangRadovich, MilanRadovich, MilanRadovich, MilanShen, FeiShen, FeiShen, FeiMiller, Kathy DMiller, Kathy DMiller, Kathy DFlockhart, David AFlockhart, David AFlockhart, David AJiang, GuanglongJiang, GuanglongJiang, GuanglongVance, GailVance, GailVance, GailGardner, LauraGardner, LauraGardner, LauraVatta, MatteoVatta, MatteoVatta, MatteoBai, ShaochunBai, ShaochunBai, ShaochunLai, DongbingLai, DongbingLai, DongbingKoller, DanielKoller, DanielKoller, DanielZhao, FengminZhao, FengminZhao, FengminO'Neill, AnneO'Neill, AnneO'Neill, AnneSmith, Mary LouSmith, Mary LouSmith, Mary LouRailey, EldaRailey, EldaRailey, EldaWhite, CarolWhite, CarolWhite, CarolPartridge, AnnPartridge, AnnPartridge, AnnSparano, JosephSparano, JosephSparano, JosephDavidson, Nancy EDavidson, Nancy EDavidson, Nancy EForoud, TatianaForoud, TatianaForoud, TatianaSledge, Jr, George WSledge, George W and Sledge, Jr, George W
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 21, (no. 22), pp. 5082-5091, November 15, 2015. | Journal Article
 
Pilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198).
Schneider, Bryan PO'Neill, AnneShen, FeiSledge, George WThor, Ann DKahanic, Stephen PZander, Paul J and Davidson, Nancy E
British journal of cancer, vol. 113, (no. 12), pp. 1651-1657, December 22, 2015. | Journal Article
2014
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.
Schneider, Bryan PLi, LShen, FeiMiller, Kathy DRadovich, MO'Neill, AGray, R JLane, DFlockhart, David AJiang, GWang, ZLai, DKoller, DPratt, J HDang, C TNorthfelt, DPerez, E AShenkier, TCobleigh, MSmith, M LRailey, EPartridge, AGralow, JSparano, Joseph ADavidson, Nancy EForoud, T and Sledge, G W
British journal of cancer, vol. 111, (no. 6), pp. 1241-8, 2014/Sep/9. | Journal Article
2013
Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial.
Schneider, Bryan PSchneider, Bryan PGray, Robert JGray, Robert JRadovich, MilanRadovich, MilanShen, FeiShen, FeiVance, GailVance, GailLi, LangLi, LangJiang, GuanglongJiang, GuanglongMiller, Kathy DMiller, Kathy DGralow, Julie RGralow, Julie RDickler, Maura NDickler, Maura NCobleigh, Melody ACobleigh, Melody APerez, Edith APerez, Edith AShenkier, Tamara NShenkier, Tamara NVang Nielsen, KirstenVang Nielsen, KirstenMüller, SvenMüller, SvenThor, AnnThor, AnnSledge, George WSledge, Jr, George WSparano, Joseph ASparano, Joseph ADavidson, Nancy EDavidson, Nancy EBadve, Sunil S and Badve, Sunil S
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 19, (no. 5), pp. 1281-9, 2013/Mar/1. | Journal Article
2012
Identification of 129S6/SvEvTac-specific polymorphisms on mouse chromosome 11.
Lo, Chiao LingShen, FeichenBaumgarner, KatherineCramer, Melissa J and Lossie, Amy C
DNA and cell biology, vol. 31, (no. 3), pp. 402-14, 2012/Mar. | Journal Article
 
Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment.
Schneider, Bryan PShen, Fei and Miller, Kathy D
The lancet oncology, vol. 13, (no. 10), pp. e427-36, 2012/Oct. | Journal Article
2011
Nuclear protein isoforms: implications for cancer diagnosis and therapy.
Shen, FeiKirmani, Kashif ZXiao, ZhiminThirlby, Benjamin HHickey, Robert J and Malkas, Linda H
Journal of cellular biochemistry, vol. 112, (no. 3), pp. 756-60, 2011/Mar. | Journal Article
 
Phosphorylation: the molecular switch of double-strand break repair.
Summers, K CShen, FeiSierra Potchanant, E APhipps, E AHickey, R J and Malkas, L H
International journal of proteomics, vol. 2011, pp. 373816, 2011. | Journal Article
2009
Dynamic assessment of mitoxantrone resistance and modulation of multidrug resistance by valspodar (PSC833) in multidrug resistance human cancer cells.
Shen, FeiBailey, Barbara JChu, ShaoyouBence, Aimee KXue, XinjianErickson, PriscillaSafa, Ahmad RBeck, William T and Erickson, Leonard C
The Journal of pharmacology and experimental therapeutics, vol. 330, (no. 2), pp. 423-9, 2009/Aug. | Journal Article
2008
Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells.
Shen, FeiChu, ShaoyouBence, Aimee KBailey, BarbaraXue, XinjianErickson, Priscilla AMontrose, Marshall HBeck, William T and Erickson, Leonard C
The Journal of pharmacology and experimental therapeutics, vol. 324, (no. 1), pp. 95-102, 2008/Jan. | Journal Article
1999
Amplification of signal transduction capacity and down-regulation by drugs.
Weber, GShen, FYang, HPrajda, N and Li, W
Advances in enzyme regulation, vol. 39, pp. 51-66, 1999. | Journal Article
 
Amplified increase in signal transduction activity in cancer cells.
Yang, HShen, F and Weber, G
Anticancer research, vol. 19, (no. 6B), pp. 4983-4988. | Journal Article
 
Sequential administration of temozolomide and fotemustine: depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours.
Gander, MColella, GennaroLeyvraz, SDecosterd, LBonfanti, MMarzolini, CShen, FLiénard, DPerey, LColella, GBiollaz, JLejeune, FYarosh, DBelanich, M and D'Incalci, M
Annals of oncology : official journal of the European Society for Medical Oncology, vol. 10, (no. 7), pp. 831-838, July 1999. | Journal Article
 
Synergistic down-regulation of signal transduction and cytotoxicity by tiazofurin and quercetin in human ovarian carcinoma cells.
Shen, FeiHerenyiova, M and Weber, G
Life sciences, vol. 64, (no. 21), pp. 1869-76, 1999. | Journal Article
 
Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells.
Shen, FeiXue, X and Weber, G
Anticancer research, vol. 19, (no. 3A), pp. 1657-62, 1999 May-Jun. | Journal Article
1998
Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration.
Marzolini, CDecosterd, L AShen, FGander, MLeyvraz, SBauer, JBuclin, TBiollaz, J and Lejeune, F
Cancer chemotherapy and pharmacology, vol. 42, (no. 6), pp. 433-440, 1998. | Journal Article
 
Role of purine metabolism in regulation of signal transduction in human carcinoma cells.
Weber, GShen, F and Li, W
Advances in experimental medicine and biology, vol. 431, pp. 401-408, 1998. | Journal Article
1997
Synergistic action of quercetin and genistein in human ovarian carcinoma cells.
Shen, Fei and Weber, G
Oncology research, vol. 9, (no. 11-12), pp. 597-602, 1997. | Journal Article
1995
Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction.
Shen, FDecosterd, L AGander, MLeyvraz, SBiollax, J and Lejeune, F
Journal of chromatography. B, Biomedical applications, vol. 667, (no. 2), pp. 291-300, May 19, 1995. | Journal Article